M
0.900
-0.05 (-5.06%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Drug Manufacturers - General (US) | 看跌 | 看涨 |
| Drug Manufacturers - General (全球的) | 看跌 | 看涨 | |
| 股票 | MIRA Pharmaceuticals, Inc. | 混合的 | - |
AIStockmoo 评分
-1.3
| 分析师共识 | -2.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | -2.0 |
| 平均 | -1.25 |
|
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. |
|
| 部门 | Healthcare |
| 行业 | Drug Manufacturers - General |
| 内部持股比例 | 19.80% |
| 机构持股比例 | 6.98% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suncoast Equity Management | 30 Sep 2024 | 90,000 |
| First American Bank | 30 Sep 2024 | 20,000 |
| Praetorian Wealth Management, Inc. | 31 Dec 2024 | 17,500 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合